Do you expect a different response rate to neradomilast depending on the ILD phenotype?

The best data to address this query come from the FIBRONEER-ILD trial, where approximately 70% of patients at enrollment had a UIP or UIP-like pattern on CT. The response to nerandomilast therapy was significant in both groups (with UIP or another pattern). In fact, the numerical results were greate...

As a rheumatologist, I am particularly interested in the autoimmune ILD subtype and reviewed with great interest the subgroup analysis published in the Annals of Rheumatic Diseases by Anna-Maria Hoffman-Vold et al., PMID 42062162, which reports specifically on the 324 patients with autoimmune ILDs (...